VISCO SHIELD Viscoelastic. Complete with 23g x 7/8" Thin Wall Cannula.
Interchangeable design allows you to select a single handpiece and change tips during the procedure. Universal connector. Disassembles for easy cleaning. Tips can rotate 360 degrees to re-orient port
Infusion Cannula, 4.0mm.
Subretinal Fluid Cannula, Curved; 20g (0.90) x 1-1/2" (38mm); 12mm Flexible Tubing Extends 6mm Beyond Tip; Curved at 65°.
Medicine Products:(Date:8/20/2008)...r-old Contestant Wins Trip to Little League Baseba... The National Spit Tobacco Education,Program (NSTE...st today,and encouraged young baseball players to...ddiction and the health risks of using tobacco pro...year,s slogan contest winner is,Joe Reck, a nine-y...
(Date:8/20/2008)...cently enacted Medicare Improvement Law immediatel...re Advantage insurance companies .../PRNewswire/ -- When the House and Senate,overrode...gislation,protecting Medicare beneficiaries, they ...e Advantage plans during one of the busiest months...
(Date:8/20/2008)...T CREEK, Calif., Aug. 20 /PRNewswire-FirstCall/ --... reported preliminary income from,continuing opera...f $27.5,million, or $0.76 per diluted share, inclu...er diluted share, related to provisions for store,... a 6.8 percent increase,compared with income from ...
(Date:8/20/2008)...FIELD, Mich., Aug. 20 /PRNewswire/ -- WXYZ- TV/Cha...llness Promotion will give thousands of,Detroit me...ALTHY LIVING,FOR KIDS" program. This year the prog....m. to 5 p.m. at the Charles H. Wright Museum of A...77, "Healthy Living for Kids",has provided free im...
Breaking Medicine News(10 mins):Health News:Slogan Contest Educates Young Baseball Players About the Dangers of Tobacco Use 2Health News:Medicare Advantage Plans Struggle to Comply With New Federal Law 2Health News:Longs Drug Stores Corporation Reports Second Quarter Results 2Health News:Longs Drug Stores Corporation Reports Second Quarter Results 3Health News:Longs Drug Stores Corporation Reports Second Quarter Results 4Health News:Longs Drug Stores Corporation Reports Second Quarter Results 5Health News:Longs Drug Stores Corporation Reports Second Quarter Results 6Health News:Longs Drug Stores Corporation Reports Second Quarter Results 7Health News:Longs Drug Stores Corporation Reports Second Quarter Results 8Health News:Longs Drug Stores Corporation Reports Second Quarter Results 9Health News:Longs Drug Stores Corporation Reports Second Quarter Results 10Health News:Longs Drug Stores Corporation Reports Second Quarter Results 11Health News:Longs Drug Stores Corporation Reports Second Quarter Results 12Health News:Longs Drug Stores Corporation Reports Second Quarter Results 13Health News:WXYZ-TV/Channel 7 is 'On Your Side' With Healthy Living For Kids; Free Immunizations for Children on Sunday, August 24 at Charles H. Wright Museum of African American History 2Health News:WXYZ-TV/Channel 7 is 'On Your Side' With Healthy Living For Kids; Free Immunizations for Children on Sunday, August 24 at Charles H. Wright Museum of African American History 3(Date:8/19/2008)...., Aug. 19 /- Particle Sciences Inc. ... polymers) development and,pilot production capabi...rusion and injection molding line. The core of the...ding extruder and Nissei 20T injection,molder, ena...lymeric,devices. This addition gives Particle Scie...
(Date:8/19/2008)...nn., Aug. 19 /- VION,PHARMA...y that it had,entered into an agreement with the D...y Oncology (the "HOVON") to conduct a clinical tri...h standard remission-induction,therapy in patients...enous,leukemia (AML) and high-risk myelodysplasia ...
(Date:8/18/2008)...g. 18 /- The next time you consider p...t might be worth counting sheep,instead. A senior ... San,Diego, Calif. has found evidence that taking ...skin cancer., Daniel F. Kripke, M.D.,s article, b...g pills and cancer, has just been published in the...
(Date:8/18/2008)...rael, August 18 /- Oramed,P....oramed.com ), a developer,of oral delivery system...en,Label Study to Assess the Safety, Pharmacokinet...sulin Formulations in Healthy,Subjects," has been ...l,Meeting of the European Association for the Stud...
Breaking Medicine Technology:Particle Sciences Expands Its Combination Product Capabilities 2Vion Pharmaceuticals Enters Into Agreement With HOVON to Conduct a Phase III Clinical Trial of Cloretazine(R) in Combination With Frontline AML and MDS Therapy 2Vion Pharmaceuticals Enters Into Agreement With HOVON to Conduct a Phase III Clinical Trial of Cloretazine(R) in Combination With Frontline AML and MDS Therapy 3Prescription Sleeping Pill Use Tied to Cancer 2Oramed Pharmaceuticals Chosen to Present Oral Insulin Trial Results at EASD Conference (September 7-11, Rome) 2Addition of INTEGRILIN 28R 29 28Eptifibatide 29 to Bivalirudin Plus Standard of Care Inhibits Platelet Aggregation in Patients Undergoing Elective Co 760 1Addition of INTEGRILIN 28R 29 28Eptifibatide 29 to Bivalirudin Plus Standard of Care Inhibits Platelet Aggregation in Patients Undergoing Elective Co 760 2Addition of INTEGRILIN 28R 29 28Eptifibatide 29 to Bivalirudin Plus Standard of Care Inhibits Platelet Aggregation in Patients Undergoing Elective Co 760 3Addition of INTEGRILIN 28R 29 28Eptifibatide 29 to Bivalirudin Plus Standard of Care Inhibits Platelet Aggregation in Patients Undergoing Elective Co 760 4Addition of INTEGRILIN 28R 29 28Eptifibatide 29 to Bivalirudin Plus Standard of Care Inhibits Platelet Aggregation in Patients Undergoing Elective Co 760 5For migrating sparrows kids have a compass but adults have the map 1116 1For migrating sparrows kids have a compass but adults have the map 1116 2Breastfeeding boost IQ in infants with helpful genetic variant 1115 1Breastfeeding boost IQ in infants with helpful genetic variant 1115 22007 Credit Suisse Healthcare Conference to Webcast Millennium Presentation 5569 12007 Credit Suisse Healthcare Conference to Webcast Millennium Presentation 5569 2...tudy results will be presented at the American Col...TO, Calif., March 06, 2007 /PRNewswire-FirstCall/ ...nalysis of unblinded,data from the MERLIN TIMI-36 ...nd in death or arrhythmias in patients on ranolazi...dpoint. , In accordance with the company,s special...
...port Ability of Higher Doses to Further Reduce Ant...8, 2007 /PRNewswire-FirstCall/ -- La Jolla,Pharmac...ntibody,results from its ongoing double-blind, pla...t(R) (abetimus sodium), its drug,candidate for sys...yses of interim antibody data indicate that patien...
Other Medicine Technology:CV Therapeutics Announces Topline MERLIN TIMI-36 Results 2CV Therapeutics Announces Topline MERLIN TIMI-36 Results 3La Jolla Pharmaceutical Announces Positive Interim Antibody Results,From Riquent Lupus Phase 3 Trial 2La Jolla Pharmaceutical Announces Positive Interim Antibody Results,From Riquent Lupus Phase 3 Trial 3La Jolla Pharmaceutical Announces Positive Interim Antibody Results,From Riquent Lupus Phase 3 Trial 4La Jolla Pharmaceutical Announces Positive Interim Antibody Results,From Riquent Lupus Phase 3 Trial 5La Jolla Pharmaceutical Announces Positive Interim Antibody Results,From Riquent Lupus Phase 3 Trial 6La Jolla Pharmaceutical Announces Positive Interim Antibody Results,From Riquent Lupus Phase 3 Trial 7